Cabaletta Bio CABA Balance Sheet (2018-2026)

NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Cabaletta Bio Quarterly Balance Sheet

Periods 31 quarters
Latest Jun 2026

Cabaletta Bio reported total assets of $256.73M and total liabilities of $46.13M for the quarter ended Jun 2026, up 55.5% year over year. This balance sheet covers 31 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Accumulated Depreciation
1.19M2.37M3.79M5.51M7.15M
Receivables - AccuredAcc. Int. Receivables
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
102.81M119.26M122.22M109.21M96.81M85.89M81.61M93.84M176.33M164.39M193.24M223.84M203.22M183.01M163.96M131.83M194.68M159.93M82.98M225.10M
Prepaid Assets
2.21M1.59M2.32M2.23M1.94M2.28M2.29M1.89M1.24M1.79M3.24M3.63M3.03M2.50M2.71M2.77M3.73M4.63M5.27M5.93M
Current Assets
105.02M120.85M124.54M111.44M98.75M88.17M108.83M95.73M177.57M166.18M244.49M227.48M206.26M185.51M166.68M134.60M198.41M164.56M138.87M231.03M
Non-Current Assets
Property, Plant & Equipment (Net)
1.60M1.46M1.44M1.23M2.31M2.81M2.58M2.59M2.30M1.99M2.54M2.92M2.98M2.81M2.74M2.64M2.37M2.06M1.92M1.48M
Long-Term Investments
Other Non-Current Assets
0.32M0.32M0.36M0.98M0.96M0.69M0.56M0.58M0.69M0.98M1.71M2.37M2.25M2.48M2.29M2.37M2.50M3.61M5.16M6.21M
Non-Current Assets
1.92M1.79M1.79M2.22M3.27M3.50M8.13M7.71M7.07M7.11M9.16M12.98M11.16M18.89M18.37M30.55M26.09M25.20M26.21M25.70M
Assets
106.93M122.64M126.34M113.66M102.02M91.67M116.97M103.45M184.64M173.29M253.65M240.46M217.42M204.41M185.05M165.14M224.50M189.76M165.08M256.73M
Liabilities
Current Liabilities
Accounts Payables
2.37M1.71M2.33M3.91M2.45M1.33M2.46M3.96M2.34M3.62M4.55M5.84M4.22M2.18M4.92M6.49M7.19M8.27M6.64M5.81M
Payables
2.37M1.71M2.33M3.91M2.45M1.33M2.46M3.96M2.34M3.62M4.55M5.84M4.22M2.18M4.92M6.49M7.19M8.27M6.64M5.81M
Accumulated Expenses
3.23M4.32M6.05M3.02M4.04M4.47M4.85M3.17M3.96M4.47M7.89M4.72M6.28M12.77M12.19M8.30M13.93M16.25M19.30M14.61M
Other Accumulated Expenses
0.05M0.05M0.05M0.06M0.02M0.07M0.04M0.05M0.02M0.03M0.04M0.05M0.02M0.03M0.04M0.05M0.02M0.03M0.08M0.06M
Current Leases
2.18M2.18M2.18M2.52M3.56M7.40M7.40M7.94M5.99M15.21M16.43M17.60M20.76M15.24M
Total Current Liabilities
5.60M6.02M8.38M6.93M6.49M5.80M9.49M9.30M8.48M10.62M15.99M17.97M17.90M22.88M27.09M33.99M41.54M45.73M50.15M39.91M
Non-Current Liabilities
Capital Leases
3.24M8.11M3.90M4.56M2.88M4.74M
Non-Current Deffered Revenue
Preferred Stock Liabilities
Operating Leases
2.96M2.49M2.01M1.75M1.46M0.77M7.29M2.38M1.49M0.58M1.49M
Total Liabilities
5.60M6.02M8.38M6.93M6.49M5.80M12.45M11.80M10.50M12.36M17.45M18.74M17.90M30.17M32.71M43.59M46.02M50.29M53.03M46.13M
Shareholder's Equity
Common Equity
101.33M116.61M117.96M106.72M95.53M85.87M104.52M91.65M174.14M160.92M236.20M221.72M199.52M174.24M152.34M121.55M178.48M139.47M112.05M210.59M
Liabilities and Shareholders Equity
106.93M122.64M126.34M113.66M102.02M91.67M116.97M103.45M184.64M173.29M253.65M240.46M217.42M204.41M185.05M165.14M224.50M189.76M165.08M256.73M
Retained Earnings
-87.14M-98.70M-112.59M-125.53M-138.44M-149.87M-165.56M-181.42M-195.90M-212.35M-233.24M-258.28M-285.89M-316.51M-349.10M-385.04M-430.17M-475.04M-516.96M-611.49M
Treasury Shares